U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C30H23N5O
Molecular Weight 469.5365
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of DACTOLISIB

SMILES

CN1C(=O)N(C2=C1C=NC3=CC=C(C=C23)C4=CN=C5C=CC=CC5=C4)C6=CC=C(C=C6)C(C)(C)C#N

InChI

InChIKey=JOGKUKXHTYWRGZ-UHFFFAOYSA-N
InChI=1S/C30H23N5O/c1-30(2,18-31)22-9-11-23(12-10-22)35-28-24-15-19(21-14-20-6-4-5-7-25(20)32-16-21)8-13-26(24)33-17-27(28)34(3)29(35)36/h4-17H,1-3H3

HIDE SMILES / InChI

Molecular Formula C30H23N5O
Molecular Weight 469.5365
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description
Curator's Comment: description was created based on several sources, including: http://adisinsight.springer.com/drugs/800026094 https://www.ncbi.nlm.nih.gov/pubmed/18606717

Dactolisib is a dual inhibitor of phosphatidylinositol 3-kinase (P13K) and the downstream mammalian target of rapamycin (mTOR) by binding to the ATP-binding cleft of these enzymes (inhibitor of PI3K/Akt/mTOR cascade). It is being investigated as a possible anti-cancer cancer agent and drug against Influenza virus infections. Frequently reported adverse events included nausea, vomiting, diarrhoea, fatigue/asthenia, anaemia, and anorexia.

Originator

Curator's Comment: https://www.google.com/patents/WO2006122806A2?cl=en # Novartis

Approval Year

TargetsConditions
Sourcing

Sourcing

Vendor/AggregatorIDURL
PubMed

PubMed

TitleDatePubMed
Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity.
2008 Jul
Dual targeting of phosphoinositide 3-kinase and mammalian target of rapamycin using NVP-BEZ235 as a novel therapeutic approach in human ovarian carcinoma.
2011 Apr 15
Comparison of the effects of the PI3K/mTOR inhibitors NVP-BEZ235 and GSK2126458 on tamoxifen-resistant breast cancer cells.
2011 Jun 1
Modulators of sensitivity and resistance to inhibition of PI3K identified in a pharmacogenomic screen of the NCI-60 human tumor cell line collection.
2012
Phosphatidylinositol 3-kinase/Akt signaling pathway activates the WNK-OSR1/SPAK-NCC phosphorylation cascade in hyperinsulinemic db/db mice.
2012 Oct
Synergistic induction of cell death in haematological malignancies by combined phosphoinositide-3-kinase and BET bromodomain inhibition.
2015 Jul
Patents

Sample Use Guides

400 or 300 mg twice daily
Route of Administration: Oral
IC50 doses of dactolisib for P3 and U87 glioma cells were established at 12.7 nM and 15.8 nM, respectively.
Substance Class Chemical
Created
by admin
on Wed Jul 05 23:09:18 UTC 2023
Edited
by admin
on Wed Jul 05 23:09:18 UTC 2023
Record UNII
RUJ6Z9Y0DT
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
DACTOLISIB
INN   USAN   WHO-DD  
USAN   INN  
Official Name English
RTB101
Code English
RTB-101
Code English
NSC-751249
Code English
dactolisib [INN]
Common Name English
2-Methyl-2-(4-{3-methyl-2-oxo-8-(quinolin-3-yl)-2,3-dihydroimidazo[4,5-c]quinolin-1-yl}phenyl)propanenitrile
Systematic Name English
2-METHYL-2-(4-(3-METHYL-2-OXO-8-QUINOLIN-3-YL-2,3-DIHYDRO-1H-IMIDAZO(4,5-C)QUINOLIN-1-YL)PHENYL)PROPANENITRILE
Systematic Name English
BEZ-235
Code English
BEZ235
Code English
DACTOLISIB [USAN]
Common Name English
Dactolisib [WHO-DD]
Common Name English
NVP-BEZ-235
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C2152
Created by admin on Wed Jul 05 23:09:18 UTC 2023 , Edited by admin on Wed Jul 05 23:09:18 UTC 2023
NCI_THESAURUS C129825
Created by admin on Wed Jul 05 23:09:18 UTC 2023 , Edited by admin on Wed Jul 05 23:09:18 UTC 2023
Code System Code Type Description
MESH
C531198
Created by admin on Wed Jul 05 23:09:18 UTC 2023 , Edited by admin on Wed Jul 05 23:09:18 UTC 2023
PRIMARY
CAS
915019-65-7
Created by admin on Wed Jul 05 23:09:18 UTC 2023 , Edited by admin on Wed Jul 05 23:09:18 UTC 2023
PRIMARY
SMS_ID
100000170045
Created by admin on Wed Jul 05 23:09:18 UTC 2023 , Edited by admin on Wed Jul 05 23:09:18 UTC 2023
PRIMARY
PUBCHEM
11977753
Created by admin on Wed Jul 05 23:09:18 UTC 2023 , Edited by admin on Wed Jul 05 23:09:18 UTC 2023
PRIMARY
FDA UNII
RUJ6Z9Y0DT
Created by admin on Wed Jul 05 23:09:18 UTC 2023 , Edited by admin on Wed Jul 05 23:09:18 UTC 2023
PRIMARY
INN
9545
Created by admin on Wed Jul 05 23:09:18 UTC 2023 , Edited by admin on Wed Jul 05 23:09:18 UTC 2023
PRIMARY
CHEBI
71952
Created by admin on Wed Jul 05 23:09:18 UTC 2023 , Edited by admin on Wed Jul 05 23:09:18 UTC 2023
PRIMARY
WIKIPEDIA
BEZ235
Created by admin on Wed Jul 05 23:09:18 UTC 2023 , Edited by admin on Wed Jul 05 23:09:18 UTC 2023
PRIMARY
ChEMBL
CHEMBL1879463
Created by admin on Wed Jul 05 23:09:18 UTC 2023 , Edited by admin on Wed Jul 05 23:09:18 UTC 2023
PRIMARY
EPA CompTox
DTXSID10238599
Created by admin on Wed Jul 05 23:09:18 UTC 2023 , Edited by admin on Wed Jul 05 23:09:18 UTC 2023
PRIMARY
DRUG BANK
DB11651
Created by admin on Wed Jul 05 23:09:18 UTC 2023 , Edited by admin on Wed Jul 05 23:09:18 UTC 2023
PRIMARY
USAN
AB-105
Created by admin on Wed Jul 05 23:09:18 UTC 2023 , Edited by admin on Wed Jul 05 23:09:18 UTC 2023
PRIMARY
EVMPD
SUB183868
Created by admin on Wed Jul 05 23:09:18 UTC 2023 , Edited by admin on Wed Jul 05 23:09:18 UTC 2023
PRIMARY
NSC
751249
Created by admin on Wed Jul 05 23:09:18 UTC 2023 , Edited by admin on Wed Jul 05 23:09:18 UTC 2023
PRIMARY
NCI_THESAURUS
C74072
Created by admin on Wed Jul 05 23:09:18 UTC 2023 , Edited by admin on Wed Jul 05 23:09:18 UTC 2023
PRIMARY
Related Record Type Details
ACTIVE MOIETY